Neurocrine Biosciences NBIX
NASDAQ NBIX
$174.41 +5.27 (+3.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Neurocrine Biosciences (NBIX) Revenue (2009 - 2026)

Updated

Analysis

Neurocrine Biosciences (NBIX) Revenue (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Neurocrine Biosciences 17.13 Bn 13.21 Bn 1.10 Bn 1.12 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.12 Bn
Jun 30, 2026 959.00 Mn
Mar 31, 2026 814.50 Mn
Dec 31, 2025 805.50 Mn
Sep 30, 2025 794.90 Mn
Jun 30, 2025 687.50 Mn
Mar 31, 2025 572.60 Mn
Dec 31, 2024 627.70 Mn
Sep 30, 2024 622.10 Mn
Jun 30, 2024 590.20 Mn
Mar 31, 2024 515.30 Mn
Dec 31, 2023 515.20 Mn
Sep 30, 2023 498.80 Mn
Jun 30, 2023 452.70 Mn
Mar 31, 2023 420.40 Mn
Dec 31, 2022 412.00 Mn
Sep 30, 2022 387.90 Mn
Jun 30, 2022 378.20 Mn
Mar 31, 2022 310.60 Mn
Dec 31, 2021 312.00 Mn
API Access

Neurocrine Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEY